Skip to content
  • 6,813 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Combined synopsis and solicitation, women-owned small business set-aside

Portfolio Impact Analysis for the Therapeutic Development Branch (TDB), NCATS

75N95024Q00564

National Institutes of Health, National Institutes of Health Nida. Administrative Management and General Management Consulting Services.

21 open like this View on SAM.gov Markdown

Awarded

Chmura Economics & Analytics, LLC

$74,146.00 obligated so far on USAspending

Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities

This one was awarded in 2024

21 like it are open now in administrative management and general management consulting services

All 21 open in administrative management and general management consulting services

Description

As published on SAM.gov.

Amendment 1 (9/11/2024): Adding Q&A as an attachment to the solicitation. See attached. The Therapeutic Development Branch (TDB) in the intramural Division of Preclinical Innovation (DPI) at the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH) was established to enable preclinical development through collaborative partnerships.

In alignment with accomplishing the Center’s mission, the Branch needs to conduct a portfolio impact analysis, from its inception in 2010 to present. The goal is to capture key metrics and evaluate the program’s research outcomes, including analyzing the economic and other quantitative and qualitative impact measures on further research and development and healthcare. TDB requires the expertise of a firm capable of conducting such types of specialized impact analyses of novel therapeutics and related technologies.

The results of this analysis will be used by Branch leadership to inform future research policy and priorities. See the attached Combined Synopsis/Solicitation, Statement of Work, and other attachments for complete requirement details.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Chmura Economics & Analytics, LLC
UEI
HGR5PWWHDMP5
CAGE
4S7Z1
Vendor location
Richmond, VA
Contract
75N95024P00671, purchase order
Obligated
$74,146.00
Actions
1 between September 26, 2024 and September 26, 2024
Competition
Competed Under SAP, 4 offers received
Set-aside reported
Women Owned Small Business
Described as
Portfolio Impact Analysis for the Therapeutic Development Branch (Tdb), Ncats
Match
solicitation number 75N95024Q00564 equals the FPDS solicitation identifier; same awarding office 75N950 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 5, 2024

    Combined synopsis and solicitation

    Due September 16, 2024 at 2:00 PM EDT. SAM.gov, notice 2e086acfc1a149a8a9594fb0e0b4d8db

  2. September 11, 2024

    Combined synopsis and solicitation

    Due September 16, 2024 at 2:00 PM EDT. SAM.gov, notice c44524dd912c4963a119b8ceb37548ef

Points of contact